Search Results - "CATO, Katherine J"

In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia by Dawson, Lee A, Cato, Katherine J, Scott, Claire, Watson, Jeannette M, Wood, Martyn D, Foxton, Richard, de la Flor, Raúl, Jones, Gareth A, Kew, James Nc, Cluderay, Jane E, Southam, Eric, Murkitt, Graham S, Gartlon, Jane, Pemberton, Darrel J, Jones, Declan Nc, Davies, Ceri H, Hagan, Jim

“…Neurokinin-3 (NK3) receptors are concentrated in forebrain and basal ganglia structures within the mammalian CNS. This distribution, together with the…”
Get full text

Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade by Wood, Martyn D, Scott, Claire, Clarke, Kirsten, Cato, Katherine J, Patel, Nisha, Heath, Jennie, Worby, Angela, Gordon, Laurie, Campbell, Lorraine, Riley, Graham, Davies, Ceri H, Gribble, Andrew, Jones, Declan N C

“…Antipsychotic drugs (APD) are widely prescribed for the treatment of schizophrenia. The APD are differentiated into typical and atypical based on the lower…”
Get more information

In Vitro and In Vivo Characterization of the Non-peptide N K3 Receptor Antagonist SB-223412 (Talnetant) : Potential Therapeutic Utility in the Treatment of Schizophrenia by DAWSON, Lee A, CATO, Katherine J, SOUTHAM, Eric, MURKITT, Graham S, GARTLON, Jane, PEMBERTON, Darrel J, JONES, Declan N. C, DAVIES, Ceri H, HAGAN, Jim, SCOTT, Claire, WATSON, Jeannette M, WOOD, Martyn D, FOXTON, Richard, DE LA FLOR, Raul, JONES, Gareth A, KEW, James N. C, CLUDERAY, Jane E

Get full text